756 completed, 237 unknown, 130 recruiting, 75 terminated. 534 Not applicable, 111 Phase 2, 98 Phase 4, 52 Phase 3, 45 Phase 1.
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safusidenib for Patients With Newly Diagnosed IDH1-mutant CNS WHO Grade 3 Oligodendroglioma and Astrocytoma - a Single Arm Phase II Study Safusidenib - Glioma : Oligodendroglioma or Astrocytoma | Phase 2 | Not yet recruiting | University of Zurich | 20 | 2027-03-01 | 2026-09-21 |
| Advanced Neurofeedback for Tinnitus Neurofeedback - Tinnitus, Subjective | Not applicable | Not yet recruiting | University of Zurich | 24 | 2027-01-01 | 2026-09-21 |
| Weekly Online CT or MR Adaptive Definitive SBRT for Regionally Metastatic Prostate Cancer weekly CT or MR online adaptive definitive SBRT - Prostate Cancer | Not applicable | Not yet recruiting | University of Zurich | 54 | 2027-01-01 | 2026-08-21 |
| Reduced-Dose Versus Full-Dose Alteplase for High-Risk Pulmonary Embolism Reduced-dose alteplase, Full-dose alteplase - Pulmonary Embolism Acute | Phase 4 | Not yet recruiting | Sahlgrenska University Hospital | 400 | 2026-12-01 | 2026-09-17 |
| The Use of Cultured (Dermal) Epithelial Autografts in Severely Burned Patients Standard of Care (SOC) - Burn Degree Second, Burn Degree Third | Not yet recruiting | University Children's Hospital, Zurich | 236 | 2026-12-01 | 2026-05-26 | |
| A Grief Support App for Adults Experiencing Bereavement Self-guided grief app (Daybreak), Waiting list - Grief | Not applicable | Not yet recruiting | Medical Research Council Cognition and Brain Sciences Unit | 80 | 2026-10-05 | 2026-10-09 |
| Early Detection of Amyloidosis in Monoclonal Gammopathy Using Nuclear Medicine Imaging ¹⁸F-florbetaben - Monoclonal Gammopathy, Monoclonal Gammopathy of Undetermined Significance (MGUS) | Not applicable | Not yet recruiting | University of Zurich | 50 | 2026-10-01 | 2026-06-03 |
| Long Term Outcome After Use of Vacuum-induced Tamponade for Postpartum Hemorrhage Postpartum Hemorrhage, Treatment Outcome | Recruiting | University of Zurich | 380 | 2026-10-01 | 2026-10-21 | |
| Pharmacoscopy for Patients With Refractory Primary Brain Tumors Pharmacoscopy 1.0 - Brain (Nervous System) Cancers, Glioblastoma | Phase 2 | Recruiting | University of Zurich | 40 | 2026-09-11 | 2026-09-21 |
| Fasting, Exercise, and Diet to Activate Autophagy in Depression Performance test - Depression - Major Depressive Disorder, Overweight (BMI > 25) | Not applicable | Not yet recruiting | University of Zurich | 120 | 2026-09-11 | 2026-06-24 |
| Effectiveness of Eccentric Cycling Exercise in Ambulatory Rehabilitation for Patients With Cardiopulmonary Diseases: A Pragmatic Randomized Controlled Trial Eccentric cycling exercise - Eccentric Cycling Exercise Training | Not applicable | Enrolling by invitation | University of Zurich | 12 | 2026-09-07 | 2026-09-11 |
| Long-Term Recovery and Quality of Life in Sepsis Survivors Care for Sepsis - Sepsis, Long Term Care | Recruiting | University of Geneva, Switzerland | 530 | 2026-09-01 | 2026-10-07 | |
| Screening for Brain Metastases gadopiclenol (contrast agent), standard contrast agent - Lung Cancer Stage IV, Melanoma Stage IV | Phase 2 | Not yet recruiting | University of Zurich | 180 | 2026-09-01 | 2026-03-25 |
| Assessment of Metabolic Changes in Response to Glcuose Intake in Women With Polyendocrine Metabolic Ovarian Syndrome (PMOS) Oral Clucose Tolerance Test (oGTT) - PCOS (Polycystic Ovary Syndrome), Insulinemic Response | Not applicable | Not yet recruiting | University of Zurich | 40 | 2026-08-01 | 2026-07-07 |
| EndoSense: Continuous Real-Time Monitoring of Health Markers in Endocrine and Metabolic Disorders Sequential Dietary Sodium Modulation - Endocrine Disorders, Hypertension | Not applicable | Active not recruiting | Felix Beuschlein | 100 | 2026-07-03 | 2026-07-27 |
| Vortioxetine for Newly Diagnosed Glioblastoma Vortioxetine - Glioblastoma | Phase 2 | Recruiting | University of Zurich | 78 | 2026-06-24 | 2026-06-29 |
| Effect of Supplemental Oxygen Therapy on Neurocognitive Performance in Healthy Highlanders Supplemental oxygen therapy, Sham intervention - Neurocognition | Phase 4 | Not yet recruiting | University of Zurich | 50 | 2026-06-18 | 2026-06-16 |
| Daily Adjustment of the Radiation Dose in MRI-guided Stereotactic Radiotherapy for Tumors in the Abdominal and Pelvic Regions SBRT with adaptive fractionation, Standard of Care (SOC) - Abdominal Tumor, Pelvic Tumor | Not applicable | Recruiting | University of Zurich | 100 | 2026-06-16 | 2026-07-07 |
| Feasibility of MR-Informed Adaptive Marker-less SBRT in Patients With Bilateral Hip Prostheses Undergoing SBRT for Localized Prostate Cancer Low-field MR-informed adaptive marker-less SBRT for definitive treatment of localized prostate cancer in patients with bilateral hip prostheses - Localized Prostate Adenocarcinoma | Not applicable | Recruiting | University of Zurich | 13 | 2026-06-09 | 2026-07-06 |
| Soy Processing and Food Allergy Skin prick test (SPT) - Soy Allergy | Not applicable | Not yet recruiting | University of Zurich | 55 | 2026-05-31 | 2026-03-20 |
Showing 20 of 1286. Sign in to see all of them.
Hypertension, Pulmonary (54) · Pulmonary Disease, Chronic Obstructive (43) · Motor Activity (42) · Altitude Sickness (41) · Hypoxia (38) · Stroke (26) · Spinal Cord Injuries (25) · Depression (22) · COVID-19 (18) · Stress Disorders, Post-Traumatic (18) · Glaucoma (16) · Pulmonary edema of mountaineers (16) · Sleep Apnea, Obstructive (16) · Coronary Artery Disease (15) · Anxiety Disorders (13)
Acetazolamide (27) · Blood Specimen Collection (13) · Magnetic Resonance Spectroscopy (11) · Oxygen (10) · Sevoflurane (10) · Exercise (9) · Cholecalciferol (8) · Observation (8) · Therapeutics (8) · Propofol (7) · Standard of Care (7) · High-Energy Shock Waves (6) · Acoustic Stimulation (5) · Surveys and Questionnaires (5) · Bevacizumab (4)
Switzerland (1132) · Germany (50) · Kyrgyzstan (43) · Italy (26) · Austria (21) · France (19) · Netherlands (19) · Spain (19) · United Kingdom (19) · Belgium (14) · United States (10) · Greece (8) · Denmark (7) · Hungary (7) · Poland (7)
Konrad E Bloch, MD (36) · Talant M Sooronbaev, MD (23) · Silvia Ulrich, Prof. Dr. (19) · Silvia Ulrich, Prof. (15) · Silvia Ulrich, MD (12) · Daniel Franzen, MD (11) · Michael Furian, MSc (8) · Reto Auer, Prof.Dr.med (8) · Georg Noll, MD (5) · Malcolm Kohler, MD (5) · Michael Furian, Prof. Dr. (5) · Talant M Sooronbaev, Prof. Dr. (5) · Talant Sooronbaev, Prof. Dr. (5)
PMID 39115183, PMID 19001265, PMID 19809295, PMID 22464647, PMID 23218404, PMID 27253988, PMID 27452767, PMID 28548301, PMID 28566523, PMID 28684261, PMID 28684262, PMID 30100576, PMID 30823913, PMID 31467191, PMID 32679209, PMID 33099797, PMID 34197151, PMID 35628896, PMID 38079468, PMID 38296630, PMID 38573759, PMID 38772577, PMID 39116869, PMID 39356039, PMID 39756820, PMID 41921908, PMID 42574109, PMID 42670759, PMID 10665494, PMID 111670, PMID 11594901, PMID 12170018, PMID 15585382, PMID 16003309, PMID 16105989, PMID 16215338, PMID 16221708, PMID 16360171, PMID 16544062, PMID 16616268, PMID 17015867, PMID 17429083, PMID 17708508, PMID 17868472, PMID 17868802, PMID 18043111, PMID 18272504, PMID 18427133, PMID 18520226, PMID 18654615
2017 (41), 2018 (32), 2016 (23), 2019 (18), 2023 (17), 2025 (11), 2015 (2)